Worth Venture Partners’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-625,080
| Closed | -$3.1M | – | 160 |
|
|
2021
Q3 | $3.1M | Buy |
625,080
+34,350
| +6% | +$170K | 1.39% | 22 |
|
|
2021
Q2 | $3.12M | Buy |
590,730
+52,335
| +10% | +$276K | 1.16% | 31 |
|
|
2021
Q1 | $2.58M | Buy |
538,395
+313,289
| +139% | +$1.5M | 1.25% | 24 |
|
|
2020
Q4 | $975K | Hold |
225,106
| – | – | 0.77% | 37 |
|
|
2020
Q3 | $927K | Sell |
225,106
-18,600
| -8% | -$76.6K | 0.76% | 33 |
|
|
2020
Q2 | $624K | Buy |
243,706
+86,564
| +55% | +$222K | 0.31% | 48 |
|
|
2020
Q1 | $454K | Buy |
+157,142
| New | +$454K | 0.28% | 49 |
|
|
2019
Q4 | – | Sell |
-77,384
| Closed | -$396K | – | 106 |
|
|
2019
Q3 | $396K | Sell |
77,384
-10,524
| -12% | -$53.9K | 0.23% | 54 |
|
|
2019
Q2 | $545K | Buy |
87,908
+28,168
| +47% | +$175K | 0.3% | 45 |
|
|
2019
Q1 | $425K | Buy |
+59,740
| New | +$425K | 0.24% | 48 |
|